Genetic biomarkers of drug resistance: A compass of prognosis and targeted therapy in acute myeloid leukemia
- 1 September 2020
- journal article
- review article
- Published by Elsevier in Drug Resistance Updates
- Vol. 52, 100703
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Hebei Province
- National Natural Science Foundation of China
- Natural Science Foundation of Beijing Municipality
This publication has 302 references indexed in Scilit:
- The C-Kit Receptor-Mediated Signal Transduction and Tumor-Related DiseasesInternational Journal of Biological Sciences, 2013
- Essential role for Stat5a/b in myeloproliferative neoplasms induced by BCR-ABL1 and JAK2V617F in miceBlood, 2012
- Acquired resistance to drugs targeting receptor tyrosine kinasesBiochemical Pharmacology, 2012
- Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencingNature, 2012
- Drug Resistance and Cellular Adaptation to Tumor Acidic pH MicroenvironmentMolecular Pharmaceutics, 2011
- Protein disulfide isomerase blocks CEBPA translation and is up-regulated during the unfolded protein response in AMLBlood, 2011
- An Alternative Splicing Network Links Cell-Cycle Control to ApoptosisCell, 2010
- RUNX1 regulates phosphoinositide 3-kinase/AKT pathway: role in chemotherapy sensitivity in acute megakaryocytic leukemiaBlood, 2009
- Response and resistance to MEK inhibition in leukaemias initiated by hyperactive RasNature, 2009
- The transcription factor HIF-1α plays a critical role in the growth factor-dependent regulation of both aerobic and anaerobic glycolysisGenes & Development, 2007